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Populations of bacteria continue to change and new pathogens have consequently emerged.  
As bacterial pathogens evolve, an increasing number of virulence factors are acquired.  
One of the most significant changes in the bacterial population is due to the introduction of 
antibiotics and subsequent increase in antibiotic resistance.  This problem poses a 
significant threat to human health.  Until new antibiotics are created or novel therapeutic 
strategies are implemented, humans are rendered defenseless during infection.  The species 
Acinetobacter baumannii has undergone significant changes and is now recognized as one of 
the most threatening pathogens due to its high antibiotic resistance profile.  What was once 
an innocuous environmental organism is now one of the greatest clinical threats.  With a 
growing prominence in healthcare, the evolution of A. baumannii is particularly unique; to 
better understand the rise to its present state, several clinical isolates of A. baumannii were 
analyzed to discern the changes that have occurred to contribute to its pathogenicity. Upon 
analysis, several intact and incomplete prophages were discovered that were contained 
within the bacterial chromosome.  Remnants of these bacterial viruses have been shown to 
be advantageous in a number of other bacteria, but no relationship to A. baumannii has 
been previously described.  In response to these changes, the conservation of bacteriophage 
genes was assessed in relation to the current increase in antibiotic resistance and virulence 
of Acinetobacter baumannii. 
 
Bacteriophages are bacterial viruses that naturally infect bacteria, integrating their own 
genetic information into the bacterial genome and become prophages.  By using bacteria as 
a host, prophages multiply with bacteria through replication.  Through lysis of the 
bacterium, bacteriophages are removed from the bacterial genome, killing their host.  
Despite this parasitic relationship, the inclusion of bacteriophage genes within a genome 
has the potential to increase the virulence of the bacteria.  Due to these beneficial changes 
in pathogenicity, bacteria have selected for these advantageous modifications.  Some 
species have even maintained defective phages within their genome, corresponding to 
progressive increases in virulence across the bacterial population. Unlike other non-
pathogenic Acinetobacter species, A. baumannii has maintained greater numbers of 
incomplete prophages within its genome, particularly that of Acinetobacter phage Bϕ-
B1251.  The acquisition and maintenance of defective phage elements appears to be 
increasing over time, suggesting that A. baumannii has undergone a directional evolution, 
selecting for the advantages bacteriophage genes confer.  
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I. PATHOGENICITY AND ANTIBIOTIC RESISTANCE 
The coexistence of humans and microorganisms has historically been documented, 
accepted, and understood.  But the human relationship with bacteria is not as straightforward as 
some believe.  As we continue to elucidate the intricacies of our connectedness with bacteria, 
these organisms continue to change.  Humans have a propensity to solely associate bacteria with 
infections; despite the bad reputation of bacteria, they also contribute to a number of beneficial 
human interactions.  The human body contains a number of microbial environments, including 
the skin, respiratory tract, gastrointestinal tract, and conjunctiva of the eyes.  In total, these 
environments contain approximately 1014 bacteria, ten times the number of human cells within 
the body (Davis, 1996).  During birth, bacteria begin to colonize these sites.  While the types of 
bacteria contained within the body continue to fluctuate, one thing remains the same: these 
bacteria are essential for health.  By competing with pathogenic species for nutrients, the normal 
bacterial flora prevent the colonization of harmful bacteria.  Others produce enzymes, such as 
proteases, peroxides, and bacteriocins capable of killing invading bacteria and denaturing 
harmful bacterial toxins (Quigley, 2013).  
While bacteria certainly confer great health advantages, not all species are beneficial.  
The term “pathogens” is applied to these species that are capable of causing disease.  Bacteria 
have been implicated as pathogens throughout the course of history; lethal plagues have 
decimated empires and resulted in the fall of rulers.  The first recorded plague, the Great 
Pestilence of Egypt, occurred in 3180 BC and is documented in the Bible (Krause, 1992).  Since 
this time, outbreaks of bacteria continue to be noted and have caused epidemics that unceasingly 
altered the course of history.   The human background is characterized by these microbiological 
threats and outbreaks such as the Bubonic Plague, cholera, typhoid fever, diphtheria, leprosy, and 
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anthrax attacks.  Not only have these events caused widespread fear and significant deaths, but 
they have also ushered in greater scientific understanding and have prompted the development of 
treatments and therapeutics. 
Even among pathogens, some are more destructive than others.  The degree of 
pathogenicity, the ability to cause disease, is termed virulence.  Bacteria have developed a 
number of mechanisms to increase their pathogenicity.  Broadly, two factors are analyzed to 
describe bacterial virulence: toxicity and invasiveness.  Toxicity describes the degree of harm 
while invasiveness describes the ability to penetrate and spread throughout a host (Beceiro, 
Tomás, & Bou, 2013).  These factors are essential in order to overcome the protective barriers of 
a host, including the populations of bacteria contained within a host.  Nevertheless, host status is 
another critical factor that must be considered when discussing pathogenicity.  Some organisms 
are only capable of infecting immunosuppressed individuals, those with weakened immune 
systems due to chronic illness, age, diet, and stress.  Pathogens that are incapable of causing 
infection in healthy people, but do cause infection in immunocompromised individuals are 
termed “opportunistic” pathogens. 
 Despite the devastation associated with bacterial illness, the discovery of antibiotics 
promised a new era of protection from bacterial pathogens.  When Alexander Fleming first 
discovered the effects of penicillin in 1928, the microbial world was transformed and a sense of 
hope emerged (Fleming, 1944).  When Fleming noticed that a mold contaminant introduced into 
his cultures of Staphylococcus aureus killed his bacteria, he was prompted to begin studying this 
strange occurrence.  It took many years for this compound to be successfully isolated before it 
was first used clinically in 1941 by Charles Fletcher (Fletcher, 1984).  The antibiotic penicillin 
was first introduced into routine hospital procedures by the Mayo Clinic in 1943 in order to treat 
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patients with bacterial infections (Herrell, 1944).  Since this time, hundreds of antibiotics have 
been developed.  These antibiotics range in effectiveness, some treating specific classes of 
bacteria (narrow-spectrum) while others target many classes of bacteria (broad-spectrum).  
 Antibiotics have become an integral component to healthcare; without antibiotics, 
bacteria would be remarkably more devastating for humans.  Before antibiotics were used as 
treatment, 30% of all deaths were attributable to bacterial infections (Fair & Tor, 2014). Today, 
this number is significantly lower.  By reducing infections, hospital stays, and mortality rates, 
antibiotics are necessary to improve patient outcome.  Despite their apparent promise, what once 
protected the health of millions is now not always a reliable treatment option.  We have used 
antibiotics for many years and have reaped the benefits they provide in controlling disease.  
However, this reliance has yielded consequences; bacteria have been exposed to the same 
antibiotics for so long that they have adapted to these medications.  The evasion and antagonistic 
ability bacteria have developed against antibiotics has been exacerbated by the acquisition of 
resistance mechanisms across bacterial populations.  This alarming trend has been compounded 
by inappropriate antibiotic use in healthcare and agriculture (Demirjian, 2015). 
With time and exposure to antibiotics, bacteria continue to acquire resistance at a 
disconcerting rate.  When antibiotics are not used by the body—due to incorrect or unnecessary 
prescriptions—increasing amounts are released into the environment and to bacterial populations 
within the body.  Not only do excess antibiotics often kill healthy, beneficial bacteria, they also 
select for strains of bacteria that are most resistant.  When faced with antibiotics, only those 
strains harboring resistance genes or possessing beneficial mutations are able to survive.  These 
bacteria proliferate and take the place of susceptible bacteria, expanding the resistant population 
(Bearson & Brunelle, 2015).  Increasing amounts of resistant bacteria also lead to increased 
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opportunities to transfer these genes to other bacteria in the environment, as resistance genes can 
be transmitted to other organisms through horizontal gene transfer. 
Antibiotic resistance has become one of the most serious threats of our time, but society 
and some healthcare workers often overlook its prevalence.  Every year approximately two 
million people become infected with bacteria that are resistant to antibiotics; of these infections, 
about 23,000 people die as a direct result of infection (Demirjian, 2015).  When bacteria develop 
resistance to some antibiotics, we must turn to other antibiotics.  This progression continues until 
bacteria ultimately become resistant to all antibiotics.  Because no approved alternative options 
exist for treatment of bacterial infections, we are left defenseless. 
Unfortunately, antibiotic-resistant organisms have adapted and acquired mechanisms that 
allow for survival, counteracting the mechanisms antibiotics use to kill or inhibit bacterial 
growth.  These organisms have undoubtedly become one of the largest threats to healthcare by 
becoming progressively more difficult to treat.  Because these resistant organisms are not easily 
eradicated, they can also be rapidly spread throughout hospitals.  These problems impact every 
aspect of healthcare; approximately $20 billion of excess is spent to treat antibiotic-resistant 
infections (Fair & Tor, 2014).  On average in the United States, patients suffering from these 
infections spend a total of 8 million extra days in the hospital and antibiotics comprise over 30% 
of pharmacy budgets (Fair & Tor, 2014). 
 
II. BACTERIOPHAGES 
 Just as humans become infected with bacteria and viruses, bacteria are also face natural 
predators in the form of bacterial viruses: bacteriophages.  These viral particles exploit bacterial 
cells for growth, integrating their own genetic information into the genome of bacteria.  Once the 
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bacteriophage genetic information has been incorporated into the bacterial genome, this genetic 
material is termed a “prophage.” These viruses may be lytic, quickly killing their host after 
replication, or they may remain lysogenic, entering a period of dormancy.  During the lysogenic 
cycle, phage DNA is integrated within bacterial chromosomes, replicating alongside host DNA 
(Fortier & Sekulovic, 2013).   
 Despite their destructive nature, both bacteriophages and bacteria confer some natural 
benefit to one another.  Bacteriophages profit from promoting the survival and proliferation of 
their bacterial hosts; when bacteria are killed, the phages they contain are also harmed.  
Bacteriophages rely on the health and replication of their hosts in order to produce more viral 
particles.  During lysogeny, bacteria often acquire enhanced fitness through increased virulence, 
pathogenicity, and stress tolerance (Fortier & Sekulovic, 2013).  Due to these advantageous 
changes, the host is protected against further phage infection and phagocytosis.  Bacteriophages 
also encode accessory genes that increase host fitness; these include increased growth under 
nutrient limitation, biofilm formation, and antibiotic tolerance.  Some prophages also encode 
regulatory switches, influencing gene expression (Bobay, Touchon, & Rocha, 2014). 
 In addition, bacteriophages also increase horizontal gene flow throughout the entire 
bacterial population, allowing genetic information to be more easily transferred between 
organisms (Chen, Golding, Sawai, Guo, & Cox, 2005).  Because bacteriophages are the most 
abundant organisms on Earth—ten times more abundant than bacteria—they harbor a substantial 
amount of genetic information.  Approximately 20% of all bacterial genomes are derived from 
bacteriophage DNA.  Of this information, a large amount confers resistance to antibiotics, 
enhances conjugation and biofilm formation, and also helps to endure a number of environmental 
stresses (Wang et al., 2010).  Bacteriophages are the single largest contributor to horizontal 
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(lateral) gene transfer—transfer of genetic information between two organisms.  Therefore, 
bacteriophages promote bacterial diversity; due to the presence and position of prophages or 
phage-like elements, virtually every strain of bacteria is unique.  Almost every organism has 
been found to contain prophages or harbor genes derived from bacteriophages (Wang et al., 
2010). 
 In order to sustain this massive population, it is necessary for phages to ensure their own 
survival and proliferation; this could not be done without their bacterial hosts.  If bacteriophages 
were solely harmful, bacteria would slowly adapt to resist phage attack.  Because phages do 
often benefit their host, bacteria continue to select for the advantageous features that prophages 
provide (Feiner et al., 2015).  In this manner, bacteria maintain these favorable traits and 
“domesticate” their prophages.  However, these domesticated elements are often removed from 
the bacterial genome when they are replaced by similar traits carried by new prophages.  
Therefore, the bacterial genome remains in a state of continuously shifting state of acquisition 
and loss of phage-derived genes (Bobay et al., 2014). 
Bacteriophages represent a major vector of bacterial genetic diversity, creating 
increasingly harmful pathogens.  A number of studies utilizing genome mining and comparative 
genomics have demonstrated the pervasiveness of prophages in the majority of bacterial 
genomes.  Not only have prophages impacted the divergence of different bacterial species, but 
they also account for significant intra-species variation in pathogenicity and virulence (Wang et 
al., 2010).  The virulence of many species of bacteria—including Escherichia coli, Streptococcus 
pyogenes, Salmonella enterica, and Staphylococcus aureus—is due to acquisition of prophages 
and phage genes (Fortier & Sekulovic, 2013).  Escherichia coli strain O157:H7, the causative 
agent of entero-hemorrhagic food poisoning, is especially virulent due to the acquisition of two 
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prophages.  These two prophages, Sp5 and Sp15, both encode Shiga-toxin production in E. coli 
O157:H7, resulting in the devastating virulence of this pathogen (Fortier & Sekulovic, 2013).  
Likewise, Vibrio cholerae, the causative agent of cholera, is only able to secrete cholera toxin 
(CT) due to the inclusion of filamentous phage CTXφ within its genome.  When pandemic 
strains of V. cholerae were compared to environmental non-toxigenic El Tor strains of V. 
cholerae, it was discovered that the El Tor strain lacked the CTXφ prophage (Canchaya, 
Fournous, & Brussow, 2004).  Prophages have also been demonstrated to have similar effects on 
other organisms, including Corynebacterium diptheriae, Clostridium botulinum, Staphylococcus 
aureus, and others (Chen et al., 2005).  Phage genes have been found to encode toxins, effector 
proteins, and enzymes including superoxide dismutase, staphylokinase, phospholipase, adhesion 
factors, and proteins involved in resistance (Fortier & Sekulovic, 2013). Therefore, the presence 
of prophages within a bacterial genome certainly does have a profound effect of the virulence of 
an organism, even among the same species. 
 Through time, prophages may not remain active and capable of lysis.  In fact, a number 
of prophages are impacted by mutations that occur in bacterial genomes.  When segments of the 
prophage are deleted or only certain genes are maintained through replication, a prophage 
becomes inactive—referred to as a “cryptic” prophage.  Despite their incomplete nature, these 
phage remnants still impact the pathogenicity and virulence of their host.  However, these events 
may not be random occurrences.  Louis-Marie Bobay, Marie Touchon, and Eduardo Rocha 
introduced the concept of phage domestication in 2014.  In this study, the dynamics of prophage 
degradation were analyzed during vertical gene transfer (from parent to offspring).  It was found 
that certain phage sequences were maintained throughout replicative events, including phage 
sequences coding for certain phage functions, particularly tail and lysis proteins (Bobay et al., 
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2014).  This study concluded that phage domestication was adaptive to individual bacteria, but 
advantageous additions were maintained by purifying selection (Bobay et al., 2014).   
A number of virulence mechanisms have been discovered to result from the maintenance 
of incomplete prophages in bacterial genomes; these conserved genes can still produce phage 
killer particles and R/F-type bacteriocins that are capable of killing sensitive cells.  Cryptic 
prophages may still be capable of forming transducing particles, phages carrying host DNA in 
place of their own, as well as gene transfer agents (GTAs) that allow for exchange of genetic 
material between bacteria.  Also, incomplete prophages present in the genome may interrupt 
assembly of other phages or bacterial functions (Bobay et al., 2014). 
The impact of cryptic prophages on pathogenicity can be demonstrated by analyzing the 
genome of Escherichia coli.  This well-known species of bacteria is significantly different than 
its closest relative, Salmonella.  In particular, the K-12 strain of E. coli has gained 18% of its 
genetic information since it diverged from Salmonella 100 million years ago (Wang et al., 2010).  
This novel information is primarily due to bacteriophages.  K-12 contains one complete Lambda 
prophage and nine cryptic prophages.  In a previous study, when all of these prophage elements 
were deleted, this strain became susceptible to one half of the normal minimum inhibitory 
concentration (MIC) of quinolone and β-lactam antibiotics, and its ability to form biofilms was 
greatly diminished.  In addition, this modified strain displayed lower rates of growth in nutrient-
poor and nutrient-rich media as well as decreased temperatures.  Therefore, cryptic phage 
elements also confer increased resistance to antibiotics and enhanced growth in stressful 




III. ANTIBIOTIC RESISTANCE: CURRENT THREATS 
 Monitoring of antibiotic resistance potential is essential in dictating treatment solutions 
and observing the evolution of bacteria.  The Centers for Disease Control (CDC) has published 
guidelines defining “Urgent,” “Serious,” and “Concerning” threats.  There are currently eighteen 
organisms identified and categorized by the CDC.  Of these three classifications, three species of 
bacteria receive the highest level of public health attention: urgent.  These bacteria are either 
causing severe outbreaks or have high potential of causing outbreaks.  Immediate public health 
intervention must be taken to limit transmission of these species, as they are difficult to prevent 
and increasingly difficult to treat.  These three antibiotic-resistant species are Clostridium 
difficile, carbapenem-resistant Enterobacteriaceae (CRE), and Neisseria gonorrheae (Prevention, 
2013). 
 Unlike urgent threats, serious threats will not immediately become public health threats, 
but are expected to worsen to become urgent with declining availability of antibiotic options.  
These threats include: multidrug-resistant Acinetobacter, drug-resistant Campylobacter, 
fluconazole-resistant Candida, extended spectrum β-lactamase producing Enterobacteriaceae 
(ESBLs), vancomycin-resistant Enterococcus (VRE), multidrug-resistant Pseudomonas 
aeruginosa, drug-resistant non-typhoidal Salmonella, drug-resistant Salmonella typhi, drug-
resistant Shigella, methicillin-resistant Staphylococcus aureus (MRSA), drug-resistant 
Streptococcus pneumoniae, and multidrug-resistant (MDR) and extensively drug-resistant 
(XDR) tuberculosis (Prevention, 2013). 
 Bacteria listed in the “concerning” category cause serious illness; while these organisms 
are resistant to a number of drugs, they remain sensitive to many therapeutic options.  Once the 
functionality of these drugs are jeopardized, these organisms could become urgent threats.  This 
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group includes vancomycin-resistant Staphylococcus aureus, erythromycin-resistant Group A 
Streptococcus, and clindamycin-resistant Group B Streptococcus (Prevention, 2013). 
The World Health Organization also warns of the dangers of antibiotic resistance.  They 
characterize antibiotic resistance as one of the three most pressing problems impacting human 
health.  The acronym ESKAPE has been developed to warn of six of the most serious multi-drug 
resistant organisms threatening healthcare: Enterococcus faecium, Staphylococcus aureus, 
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter 
spp. (Howard, O'Donoghue, Feeney, & Sleator, 2012).  These species of bacteria comprise the 
causes of the majority of nosocomial (hospital-acquired) infections and are particularly difficult 
to control within the hospital setting. 
 
IV. THE EMERGENCE OF ACINETOBACTER BAUMANNII 
Within the span of a few years, Acinetobacter baumannii has become ubiquitous in 
healthcare, capable of causing a number of infections.  Recognized as a “serious” threat by the 
Centers for Disease Control, this species of bacteria had not become widely recognized until 
recently.  This species is an opportunistic pathogen, infecting critically ill and 
immunocompromised individuals, including newborns, elderly, pregnant women, and other 
diseased individuals.  A. baumannii is characterized as a strictly aerobic, non-fermenting, non-
fastidious, non-motile, catalase-positive, oxidase-negative Gram-negative cocco-bacillus 
(Howard et al., 2012).  It is not a member of the normal flora of the skin or other human 
environments, meaning that it is considered a true pathogen when isolated from human sources. 
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A. baumannii is capable of causing a number of infections, often targeting moist tissue, 
such as mucous membranes (Howard et al., 2012).  While A. baumannii most commonly causes 
community- and hospital-acquired pneumonia, it is also a notable cause of meningitis, 
bacteremia, wound infections, and urinary tract infections, with minor implications in other 
infections.  Due to its unique ability to form biofilms, it is capable of colonizing the surface of 
the lungs, endotracheal tubes, urinary tract, and the eyes, resisting extraction by mechanical 
defenses such as coughing, urination, and blinking (Peleg, Seifert, & Paterson, 2008).  Biofilms 
are colonies of bacterial that aggregate together and form a community physically held together 
by an extracellular polymeric substance (EPS) matrix (Donlan, 2002).  Biofilms require exposed 
surfaces for attachment, but once formed, become sturdy masses of bacteria that resist 
mechanical removal and chemical destruction, including death by antibiotics.  The formation of 
biofilms makes this pathogen especially threatening in a hospital environment, as it can colonize 
all surfaces in hospitals including counters, ventilation tubes, and catheters. 
The presence of A. baumannii is also felt within our own community.  A. baumannii is a 
frequently encountered pathogen in hospitals in Louisville, Kentucky, and has been notable for 
many years.  The occurrence of this pathogen was analyzed at one single hospital in Louisville 
beginning in 2010.  Considering the number of hospitals found in this one city, the impact of A. 
baumannii is actually much greater in this community.  While it is associated with a number of 
varying infections at one specific hospital, it is most commonly associated with respiratory and 
wound infections (Table 1).  Unfortunately, this data does not reflect the increasing rates of 
multi-drug resistant Acinetobacter in this hospital.  Although the numbers of infections do not 
change significantly each year, based on this data, it is likely that a greater percentage of those 
isolated in 2016 are multi-drug resistant than the percentage seen in 2010. 
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The first strain of Acinetobacter was isolated from the soil in 1911, originally named 
Micrococcus calco-aceticus.  The name of this organism was officially changed in 1971 to 
Acinetobacter, and today this genome comprises 48 species.  Members of this genus are 
commonly isolated in the environment in soil and water, with the exception of A. baumannii.  
The species A. baumannii has yet to be isolated in the environment; rather, it is routinely isolated 
in hospital settings as a pathogen (Howard et al., 2012).  The genus Acinetobacter remained 
largely innocuous throughout history, only isolated from the environment; the emergence of A. 
baumannii as a pathogen in the past few decades symbolized a significant shift.  The first clinical 
account of A. baumannii was published by Schaub and Hauber in “A Biochemical and 
Serological Study of a Group of Identical Unidentifiable Gram-negative Bacilli from Human 
Sources” in 1948. The organisms in this study were originally identified as Neisseria species 
until it was noted that they failed to reduce nitrates.  Rather than recognizing these species to be 
A. baumannii at this time, these isolates were referred to as Bacterium antinatratum and later 
identified to be a pathogenic Acinetobacter species (Schaub & Hauber, 1948). 
Since 1948, this species has become increasingly more recognized in healthcare.  In an 
article written in 1996 by Bergogne-Bérézin and Towner, A. baumannii was still described as a 
“relatively low-grade pathogen” (Bergogne-Bérézin & Towner, 1996).  However, this pathogen 
has been gaining much more respect due to its successful virulence mechanisms and extensive 
antibiotic resistance profile, resulting primarily from the high degree of plasticity of its genome.  
In one study, significant differences were found in two A. baumannii clinical isolates taken from 
the same patient one week apart (Hornsey et al., 2011).  One strain was taken prior to the patient 
beginning tigecycline therapy, while the other was obtained one week afterwards.  During a 
single week, this organism accumulated a number of mutations within its genome that conferred 
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resistance to many antibiotics, including tigecycline (Hornsey et al., 2011).  Studies such as this 
demonstrate the rapid evolution that A. baumannii is able to undergo in a very short time.  
In the past, clinical isolates of A. baumannii were successfully treated with 
aminoglycosides, β-lactams, quinolones, and tetracyclines including genatmicin, minocycline, 
nalidixic acid, ampicillin, or carbenicillin; these antibiotics were successful in treating infections 
until resistance to these antibiotics was noted around 1975 (Bergogne-Bérézin & Towner, 1996).  
According to an article written by Bergogne-Bérézin and Towner in 1996, carbapenems such as 
imipenem and meropenem were the therapies of choice for A. baumannii infections.  At this 
time, carbapenems were effective on “100% of strains” (Bergogne-Bérézin & Towner, 1996).  
However, the same is not true today; in a study conducted from 2008-2011 in a university 
hospital, 76% of A. baumannii isolates were resistant to meropenem and 79.5% of A. baumannii 
isolates were categorized as multi-drug resistant (Townsend et al., 2015).  Although carbapenem 
resistance is quite common today, carbapenems are typically still considered the drug of choice.  
When carbapenem resistance is detected, treatment usually changes to include either sublactam 
or polymyxins, such as colistin (Peleg et al., 2008).  However, resistance to each of these classes 
has also been reported.  In fact, pan-drug resistant strains of A. baumannii, resistant to all current 
antibiotics, have also been reported (Peleg et al., 2008).  If one becomes infected with a pan-drug 
resistant strain, no current antibiotic could be used for therapy. 
While little clinical information exists about A. baumannii before the 1970s, it is widely 
assumed that the species was sensitive to most antibiotics.  Because Acinetobacter infections 
were likely easily treatable, it was not regarded as a threat.  Beginning in Europe in the early 
1980s, documented hospital outbreaks of A. baumannii were described in England, France, 
Germany, Italy, Spain, and the Netherlands (Peleg et al., 2008).  The subsequent spread A. 
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baumannii infection across the world is likely due to transportation and travel of colonized 
patients.  In 1991 and 1992, outbreaks of carbapenem-resistant A. baumannii were reported from 
a New York City hospital; these strains were multi-drug resistant, only susceptible to polymyxins 
and ampicillin-sublactam.  Since this time, this pathogen has been prominent in United States 
hospitals; the National Nosocomial Infection Surveillance system reported significant increases 
in resistance to amikacin, ceftazidime, and imipenem from 1986 to 2003 in the United States.  
However, the prominence of A. baumannii was especially noted beginning in March 2003, 
following the Iraq war.  At this time, a number of soldiers suffered infected battle wounds due to 
this organism, leading to the nickname “Iraqibacter.”  This organism was later determined to 
have not been obtained from the environment or during battle, but rather from infected surfaces 





V. ANALYSIS OF ACINETOBACTER BAUMANNII  
 
The relationship between bacteriophages and Acinetobacter baumannii has never been 
documented in scientific literature.  Due to the correlation between phage elements and 
virulence—such as antibiotic resistance—in a number of other organisms, including Escherichia 
coli, Vibrio cholerae, Pseudomonas aeruginosa, Shigella dysenteriae, Salmonella enterica, and 
Streptococcus pyogenes (Chen et al., 2005; Fortier & Sekulovic, 2013; Hosseinidoust, van de 
Ven, & Tufenkji, 2013; Wagner & Waldor, 2002) I hypothesize that the acquisition of cryptic 
prophage elements within the Acinetobacter baumannii genome corresponds to the sudden 
increase in virulence and rapid evolution observed in this organism.  Because A. baumannii is 
distinctly different from other species of Acinetobacter, which are not normally pathogenic, the 
acquisition and harboring of phage elements may correlate to the pathogenic potential of A. 
baumannii in contrast to non-baumannii Acinetobacter species.  The inclusion of cryptic 
prophages within the genome throughout the history of A. baumannii may suggest that this 
species has undergone purifying selection in order to maintain and contribute to the rapid rise in 
virulence.  Phage elements may also serve as active regulatory switches in A. baumannii, as they 
do in other species (Feiner et al., 2015). 
 
 
a. Discovery of Novel Genetic Material 
Two clinical isolates of A. baumannii, BR097 and BU310 were analyzed in order to 
better understand the pathogenicity of this organism.  Both isolates were obtained from a single 
patient in 2012, although each is a different strain; BR097 was isolated from a respiratory 
specimen, while BU310 was isolated from urine.  Because significant genotypic and phenotypic 
differences, it is assumed that each isolate was obtained independently of the other.  The whole 
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genome shotgun sequencing projects for each specimen can be accessed through the NCBI 
database (Accession numbers NZ_JNFY00000000.1 and NZ_JNFZ00000000.1).   
 When A. baumannii strains BR097 and BU310 were first analyzed, the two strains were 
aligned against a reference strand of A. baumannii (ATCC 17978), isolated in 1951, to begin to 
analyze the differences in each.  A. baumannii ATCC 17978 (Accession: NZ_CP018664.1) was 
previously completed to produce a whole chromosomal sequence, while the sequences of both 
BR097 and BU310 were incomplete.  By aligning the contiguous segments of BR097 and 
BU310 to strain ATCC 17978, a draft quality chromosomal sequence was established for both 
strains.  Alignment was achieved by using online bioinformatic software; both RAST: Rapid 
Annotation Using Subsystem Technology (Aziz et al., 2008; Brettin et al., 2015; Overbeek et al., 
2014) and Mauve (A. C. E. Darling, Mau, Blattner, & Perna, 2004; A. E. Darling, Mau, & Perna, 
2010) were utilized to establish alignment. 
Upon alignment of these different isolates, a number of gaps were present within the 
chromosomal map (Figure 2).  Such gaps represented DNA that was not contained in the 
reference A. baumannii ATCC 17978 genome.  Indeed, this DNA was novel genetic information 
contained within the genomes of A. baumannii BR097 and BU310.  Because it was not contained 
in the original reference strain of A. baumannii from 1951, it is likely that this information was 
either acquired through evolution prior to appearing in these two isolates or this information was 
acquired directly by these two isolates by mechanisms such as lateral gene transfer. 
  
b. Identification of Phage Genes 
These novel sequences were then annotated to determine where they originated and to 
understand the role they played in A. baumannii.  A number of software programs were used to 
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identify code determining sequences and open reading frames contained within this DNA; those 
sequences that potentially coded for proteins were further analyzed to understand what kind of 
protein it codes for based on conserved domains, amino acid residues, transmembrane helices, 
and signal peptides.  Software used included BLAST: Basic Local Alignment Search Tool, 
CDD: Conserved Domain Database Search, T-Coffee (Di Tommaso et al., 2011), WebLogo 
(Crooks, Hon, Chandonia, & Brenner, 2004), TMHMM: Transmembrane Helix Hidden Markov 
Models, SignalP, PSORT-b (Gardy et al., 2003), and Phobius (Kall, Krogh, & Sonnhammer, 
2004). 
After annotation and analysis, the majority of this novel DNA was determined to 
originate from bacteriophages and code for phage-related functions based on sequence homology 
and conserved domains.  The PHAST (Zhou, Liang, Lynch, Dennis, & Wishart, 2011) and 
PHASTER (Arndt et al., 2016) prophage search tools were used to identify areas of intact, 
incomplete, and questionable prophage sequences from a library of prophage sequences.  One 
intact prophage and a number of incomplete prophages were identified in both strains BR097 and 
BU310; they harbor an intact Psychrobacter Psymv2 phage as well as many incomplete 
Acinetobacter Bφ-B1251 phages (Table 3 and 4). 
Therefore, the acquisition of genetic information directly from bacteriophages has altered 
the genetic makeup of these strains.  The prophage-imposed diversity among these three strains 





c. Analysis of Prophage Inclusion Among Other Acinetobacter baumannii Strains  
In order to understand the evolutionary impact prophages may have on the development 
and expansion of antibiotic resistance in A. baumannii, other previously sequenced strains were 
analyzed to determine if they harbor prophage elements. The genomes of twenty-two clinical 
isolates of Acinetobacter baumannii were obtained from the public databases of the National 
Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/genome/) (Table 
2).  These strains were chosen to represent a continuum of time, isolated beginning in 1950 
through today.  Together, these twenty-two strains represent a diverse group of isolates, differing 
in specimen source, geographical location, and antibiotic resistance patterns. 
 As before, the PHAST (Zhou et al., 2011) and PHASTER (Arndt et al., 2016) prophage 
search tools were used to identify areas of intact, incomplete, and questionable prophage 
sequences based on the number of genes present, the homology, and the function of the genes.  
Those marked as “incomplete” or “questionable” harbored genes that were identified in a 
specific phage, although not all of the genes of the bacteriophage are found within the bacterial 
host.  To properly classify each region, a score is generated (guidelines established by 
phaster.ca); a score of 150 is considered a perfect score while scores of >90 are considered intact, 
70-90 is considered “questionable,” and <70 is considered “incomplete” (Arndt et al., 2016; 
Zhou et al., 2011).   
After analysis, it was found that all but one strain of A. baumannii contained two or more 
phage elements (Table 2).  The one strain that did not contain phage genes, AYE, did acquire a 
resistance island that accounts for its virulence (Howard et al., 2012).  Resistance islands are 
groups of resistance genes in a single segment of DNA that are passed horizontally between 
bacteria; these mobile elements are continuously lost and gained.  The CIP70.10 strain, isolated 
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in 1950, contained two prophage elements (one intact and one incomplete) while the AB030 
strain, isolated in 2014, contained fifteen prophage elements (four intact and eleven incomplete).  
There is obvious difference between these strains isolated 64 years apart.  As anticipated, other 
A. baumannii strains isolated recently displayed similar patterns to our own isolates BR097 and 
BU310; all of these strains have seemed to maintain defective prophages, as well as intact 
prophages, within their genome. 
With the exception of AYE, all other strains maintained at least one defective 
(incomplete) prophage within their genome (Tables 3 & 4).  However, these strains were less 
likely to harbor intact prophages (Tables 3 & 4).  Of the twenty-two isolates studied, six of the 
strains carried no intact prophages.  Among the strains that did contain an intact prophage, the 
quantity of these phages was also significantly less than the number of incomplete prophage 
elements maintained.  Most strains only carry one intact prophage while multiple incomplete 
elements are found in a single strain. 
 
d. Relationship of Phage Domestication to Antibiotic Resistance and Virulence 
 Upon analyzing the placement of cryptic (incomplete) prophage elements within the 
genomes of A. baumannii BR097 and BU310, a phage replication initiation protein (Inoviridae 
protein Gp2) was identified that lied downstream from an RND multidrug efflux transporter and 
membrane fusion protein, as well as a transcriptional regulator (AraC) (Figure 2).  In order to 
determine if phage genes had any effect on the antibiotic resistance potential within a strain, the 
same twenty-two isolates were also analyzed to identify antibiotic resistance genes. 
 The Comprehensive Antibiotic Resistance Database (CARD) (card.mcmaster.ca) was 
used to identify resistance genes by comparing the protein-coding sequences of an organism to 
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the database of sequenced resistance genes (Jia et al., 2017).  This program is able to identify 
“perfect,” “strict,” and “loose” matches to known resistance genes.  For this project, only 
“perfect” matches were searched in order to maintain reliable identification across all strains.  
Table 5 lists the resistance genes identified in each strain.  These resistance genes contribute to 
resistance of different antibiotics through differing means; Table 6 summarizes the number of 
genes, the resulting resistance patterns, and the different mechanisms a strain may use to resist 
antibiotics.  
 
e. Analysis of Prophage Inclusion in Other Acinetobacter Species 
As previously described, Acientobacter baumannii is the only true pathogen within the 
genus Acinetobacter.  With the exception of A. baumannii, other Acinetobacter species are 
ubiquitous in nature.  Nonpathogenic species can be isolated from almost any environmental 
source, especially in soil, wastewater, and as human normal flora (Al Atrouni, Joly-Guillou, 
Hamze, & Kempf, 2016; Peleg et al., 2008).  There are currently 48 species of Acinetobacter 
identified by the NCBI.  A. nosocomialis, A. pittii, A. ursingii, A. haemolyticus, A. lwoffii, A. 
parvus, A. junii have been implicated in a few isolated human infections, although they are not 
typically considered human pathogens (Touchon et al., 2014). 
 The environment could potentially serve as a reservoir for antibiotic resistance in other 
Acinetobacter species.  Non-baumannii strains isolated from hospital sewage, agricultural runoff, 
and polluted surface waters have been found to produce carbapenemase and extended-spectrum 
beta lactamase (ESBL) enzymes (Al Atrouni et al., 2016).  Resistance genes are easily spread in 
the environment; Acinetobacter is particularly well-suited for the natural environment, as this 
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genus is able to resist desiccation and can survive in unfavorable, nutrient-limited conditions for 
long periods of time (Al Atrouni et al., 2016; Peleg et al., 2008). 
 If other Acinetobacter species are also capable of acquiring resistance mechanisms such 
as antibiotic-inactivating enzymes, why is A. baumannii the only true pathogen?  In order to 
differentiate A. baumannii from other Acinetobacter species, other sequenced species of 
Acinetobacter were also analyzed to determine their prophage content (Table 9).  The PHAST 
and PHASTER programs were utilized for this analysis.  Due to their low degree of 
pathogenicity, fewer strains of other species have been sequenced and made available through 
the NCBI.  Those that were available were analyzed, but represent an altered view of this 
population, as many of these strains were involved in rare human infections and have hence been 
studied.   
After analysis, all but one strain (A. calcoaceticus PHEA-2) of non-baumannii 
Acinetobacter spp. harbored an intact or incomplete prophage.  Unlike most strains of A. 
baumannii, these strains frequently only harbored a single phage that was often intact.  The 
diversity of phages identified in these strains presented with a much greater variety than those of 
A. baumannii (Table 10).  Phages identified from other Acinetobacter species included 
Enterobacteria phage mEp235, Psychrobacter phage pOW20, Burkholderia phage phiE255, 
Pseudomonas phage PhiCTX, Haemophilus phage SuMu, and many others.  Acinetobacter 
phage Bϕ-B1251 was isolated in nine of the twenty-one other species analyzed, a much lower 




VI.  DISCUSSION 
i. Acquisition of Novel Genetic Material 
 This data indicates that A. baumannii has acquired a significant amount of novel genetic 
material and continues to evolve through the years.  As previously determined by numerous 
studies, the genome of A. baumannii has a high degree of plasticity and is easily made competent 
(Imperi et al., 2011).  Therefore, the genome of A. baumannii is expected to be in constant flux 
as genetic changes occur.  However, elements that remain within the genome despite these 
perturbations likely are significant to the change in pathogenicity of this organism.  In this study, 
numerous changes were observed among these strains of A. baumannii; most of these changes 
could not be tracked over time and were, therefore, temporary elements.  Some of these changes 
included acquisition of resistance genes that were not observed in other populations of this 
organism, as well as loss of intact prophages.  Despite the inherent variability among strains, 
patterns were identified that were consistent among strains and are, therefore, significant. 
 
ii. Integration of Phage Elements 
Indeed, prophages represent the largest reservoir of variability in A. baumannii.  While a 
number of intact phages were identified, most of the phage genes that were discovered within the 
genome of A. baumannii were, however, not intact phages.  As the ultimate goal of a prophage is 
lysis (extraction from the host genome), whether from lytic or lysogenic life cycles, the 
perpetuation of prophages within the host genome is not expected to occur.  Upon lysis, 
prophage elements are typically rapidly excised from the host, leaving very little, if any, genetic 
material behind. When mutations or deletions occur to the phage and it is no longer capable of 
lysis, the remaining segments of the genome persist within the host genome.  These defective 
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“cryptic” prophages were commonly observed in A. baumannii, suggesting previous infection 
with the same prophage. 
When analyzing prophage elements, it was noted that A. baumannii strains BR097 and 
BU310 tended to especially preserve segments coding for structural phage components including 
those for major capsid, integrase, and tail proteins.  These components are typically found on the 
ends of intact prophages, assisting the phage with integrating into and extracting itself from the 
host genome.  This finding is consistent with other studies that identified that genes encoded in 
the internal parts of a prophage, such as packaging genes, are more commonly removed than 
other genes located on the outer edges of a prophage (Bobay et al., 2014).  There is still no 
explanation as to why these genes are conserved as opposed to others; future studies are needed 
to elucidate the selective processes that occur to maintain these genes. 
Such extraneous material within the genome of an organism was often believed to be a 
negative event, compromising host fitness.  Regardless of the type or function of the conserved 
genes, it is known that the insertion of foreign DNA, specifically bacteriophage DNA, into the 
bacterial chromosome certainly impacts the regulation and, therefore, function of bacteria.  Ron 
Feiner described the consequences of chromosomal disruption by bacteriophages in 2015; he 
suggests that insertions into essential regions for function or regulation would not be tolerated 
and would, therefore, not be passed along to other generations.  However, these insertions may 
be tolerated in situations where the integration of the phage would be among genes that were 
non-essential or only required in specific conditions, such as virulence factors (Feiner et al., 
2015). 
In A. baumannii BR097, phage insertion points were primarily in regions of the genome 
rich in genes coding for antibiotic resistance, fimbiral adhesion, and pilus assembly proteins, 
	 27 
among others.  While these genes certainly influence the virulence of this organism, these genes 
are not necessary for survival.  Despite the disruptive connotation phage genes carry in these 
accounts, they may not only be merely tolerated, but they may actually prove advantageous for 
their host.  The location of integration must certainly not interfere with viability, but as long as 
the host is able to maintain or have very minimal detriment to its overall fitness, maintaining a 
cryptic prophage does not harm a host.  In fact, the interactions phage genes experience with 
non-essential genes, such as virulence factors, may actually promote the expression of these 
defenses. 
Such observations have been noted in other pathogenic bacteria, including Shigella 
dysenteriae, Salmonella typhimurium, and Salmonella typhi. In Shigella dysenteriae, the shiga 
toxin genes are surrounded on each side by isolated phage genes.  The same phenomenon also 
occurs surrounding the sopE2 (involved in invasion of human epithelial cells) gene in S. 
typhimurium and the sspH (promotes attachment to host cells) and pertussis-like toxin genes in S. 
typhi (Canchaya et al., 2004).  Other studies also suggest that the integration of phages within 
genes and operons actually may function as regulatory switches (Feiner et al., 2015).  
While further studies are indicated, numerous instances of phage proteins located next to 
transcriptional regulators and antibiotic resistance genes, such as RND multidrug efflux pumps 
were found within our two clinical isolates of A. baumannii, suggesting that the species A. 
baumannii may experience similar phage interactions.  One example is displayed in Figure 1.  In 
this instance, a gene coding for a phage replication initiation protein (Inoviridae Gp2) was found 
upstream from genes coding for RND multidrug efflux pumps as well as transcriptional 
regulators.  The clustering of phage genes nearby host genes coding for virulence factors and 
regulatory functions is likely not random.  I theorize that the integration of phage genes in these 
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areas alters the regulation and expression of virulence factors such as antibiotic efflux pumps.  
Although all strains of A. baumannii inherently contain efflux pumps, those that are the most 
virulent (i.e. antibiotic resistant), are more recent strains that have acquired more phage 
elements, especially incomplete elements.  Because phage genes are commonly found nearby 
genes encoding virulence factors, it is likely that a relationship does exist. 
 
iii. Prophage Inclusion in the Acinetobacter baumannii Population 
Significant amounts of prophage content were also discovered in other global strains of 
A. baumannii.  Among the twenty-two isolates of A. baumannii that were studied, notable 
differences in geographic location, date of collection, and type of infection exist.  However, 
similarities and trends can be discerned within the whole population, despite the apparent 
variance. 
Both intact and incomplete prophage elements were found in A. baumannii strains, 
although the inclusion of incomplete elements was much more pervasive; incomplete elements 
were found in greater numbers and incomplete elements were even discovered in genomes that 
lacked intact prophages (see LAC-4 and BJAB0868).  Cryptic (incomplete) prophages were 
observed in all but one strain (AYE), as previously discussed.  In the twenty-one strains 
containing cryptic prophages, all harbored at least one element originating from Acinetobacter 
phage Bϕ-B1251 (also referred to as YMC/09/02/B1251). 
The consistency observed in carrying prophage elements derived from this specific phage 
suggests that A. baumannii may have a preference for maintaining it.  This is likely not random; 
as other studies have suggested, such similarity often results from a single ancestral phage 
insertion or from multiple integrations of the same phage over time (Bobay et al., 2014).  As 
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discussed earlier, it is particularly unlikely for an intact phage to persist within a genome for long 
periods of time, as they will eventually lyse and kill their host.  Intact prophages are also subject 
to rapid degradation by the host with time.  Once defective, the phage carcass remains within the 
host.  Because the same defective prophage continues to be found across the majority of strains, 
beginning as early as 1951 and continuing through today, it is probable that some of these 
elements were maintained through replication and evolution.  Since they are not lost from the 
genome through lysis, they are more likely to be maintained as long as they do not confer a 
considerable fitness burden for the cell. 
 
iv. Relationship of Phage Domestication to Antibiotic Resistance and Virulence  
 Mechanisms of antibiotic resistance are not always straightforward and may require 
phenotypic testing to truly elucidate resistance profiles.  Some bacteria are intrinsically resistant 
to certain antibiotics based on physical characteristics—due to differences such as thick 
peptidoglycan cell walls in Gram positive bacteria and lipopolysaccharide in Gram negative 
bacteria—they may have indirect means of resisting antibiotics (such as forming biofilms or 
decreasing the number of porins), or they may acquire mutations to existing resistance 
mechanisms or regulatory pathways (Adams, Chan, Molyneaux, & Bonomo, 2010; Hornsey et 
al., 2011; Munita & Arias, 2016).   
Consequently, it is nearly impossible to interpret an organism’s resistance capability 
based solely on genomic studies.  Phenotypic susceptibility studies are often necessary to 
determine a resistance profile, as performed by clinical microbiology laboratories.  Therefore, 
analysis by the CARD list was not comprehensive and does not consider intrinsic resistance, 
secondary mechanisms, and altered proteins (such as pbps—penicillin binding proteins).  
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However, the resistance profiles obtained from the CARD database can still provide an adequate 
surmise toward the actual resistance profiles of each strain. 
Overall, A. baumannii does continue to constantly acquire new resistance genes with 
time.  The specific genes it acquires also changes with time, likely in response to changing 
recommended antibiotic regimens.  Older resistance genes are sometimes lost or are replaced.  
One notable trend was the eventual elimination of adeR from the genome of A. baumannii 
isolates (Table 5).  This gene regulated antibiotic resistance to tetracyclines and aminoglycoside 
antibiotics by regulating the adeABC efflux pump (CARD, Table 7)(Higgins, Schneiders, 
Hamprecht, & Seifert, 2010).  adeR was commonly found in the A. baumannii genome from 
1951-2004, but the last time it was seen in a representative A. baumannii genome was 2008 
(Table 5).  This change was actually due to a novel mutation within the adeR gene, impacting its 
regulation of the adeABC efflux pump and resulting in overexpression of adeABC and, 
therefore, increased resistance to tetracycline and aminoglycoside antibiotics (Higgins et al., 
2010).  Tigecycline is currently a popular choice in therapy against A. baumannii, but its 
effectiveness is now jeopardized because of this mutation. 
This is just one example of the various mutations and mechanisms A. baumannii has 
acquired to become more virulent.  Due to the complexity of genetic interactions and factors 
associated with antibiotic resistance, it is difficult to attribute the rise of antibiotic resistance in 
A. baumannii solely to the acquisition of cryptic prophage elements.  However, antibiotic 
resistance continues to increase, paralleling the increase in cryptic prophage elements in A. 
baumannii.  A connection between these two elements may, indeed, exist, but the exact 
mechanism is unable to be discerned at this time. 
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v. Prophage Inclusion in Other Acinetobacter species 
 Among the genus Acinetobacter, A. baumannii is the only true pathogen—but what 
accounts for this difference? While other species are capable of causing human infections, they 
predominantly remain susceptible to most antibiotics.  Numerous studies have failed to 
understand why the lifestyle of A. baumannii is distinctly unique.  A number of theories have 
been proposed, including unique gene clusters (including genes coding for integrases, type IV 
secretion systems, pilus biogenesis, iron uptake, and metabolism functions) (Peleg et al., 2008) 
as well as differences in transcriptional regulators (Adams et al., 2010).  These propositions may 
be true, but it is possible that these differences may even have originated from phages.  
Bacteriophages are one of the largest vehicles of horizontal gene transfer and, by definition, 
introduce foreign DNA into organisms; it is not unlikely that this is how A. baumannii acquired 
these differences and, as a consequence, became more virulent. 
 Phage domestication by purifying selection certainly seems to occur in A. baumannii, but 
other scientists studying this organism have overlooked this basic concept.  The implications of 







Our community is not immune to the effects of antibiotic resistance, including that 
caused by Acinetobacter baumannii.  Everyone’s life is impacted by this threat, whether evident 
or not; our healthcare bills continue to increase, infections become more devastating, treatments 
no longer exist, and we are left defenseless against an enemy we once easily controlled.  A. 
baumannii has established its place in our community whether we recognize it or not.  As seen in 
by the clinical data in Table 1, A. baumannii continues to cause a steady number of hospital 
infections.  This organism will not be eradicated anytime soon.  The data, however, does not 
reflect the changes this species has undergone; the strains we encounter today are often 
significantly more virulent, and, therefore, more deadly than those of previous years. 
A. baumannii has undoubtedly experienced changes over time, most notably by 
acquisition of phage genes.  Within the A. baumannii species, increasing numbers of prophage 
elements are acquired throughout its evolution.  When the first strain of this organism, isolated in 
1950, was sequenced, it contained only minimal prophage content.  Significant differences are 
observed in the most recently isolated strains.  The total amount of genetic material obtained 
from bacteriophages (Graph 1) continues to rise exponentially from 1950 to today.  Similar 
patterns are seen in prophage content solely from defective (incomplete) prophages (Graph 2), as 
well as prophage content exclusively from Acinetobacter phage Bφ-B1251 (Graph 3).  These 
patterns are remarkably similar because of the total prophage content harbored in strains of A. 
baumannii, the majority of the content is due to incomplete prophages.  Also, among the 
inclusion of cryptic prophages, the majority of these defective prophage remnants originated 
from Acinetobacter phage Bφ-B1251.  Relatively consistent numbers of intact prophages are 
maintained, as they are continually gained and removed from the organism’s DNA.  Therefore, 
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intact prophages have no true impact on the evolution of this species; prophages only impact A. 
baumannii once they have lost their function and become cryptic.  Even when such mutations 
occur, A. baumannii still appears to maintain selective pressure over the specific elements it 
retains. 
This single species is strikingly different than other species within the genus 
Acinetobacter.  The most obvious difference between this true pathogen and the environmental 
species it is closely related to appears to be delineated by prophage content.  While non-
baumannii species certainly also harbor phages, as most bacteria do, these phages and phage 
conservation patterns differ from those of A. baumannii.  This species has undoubtedly 
maintained a significant amount of defective prophages—an occurrence that is only occasionally 
observed in other Acinetobacter species.  Whether A. baumannii is inherently more competent 
than other species, and thus is more prone to acquisition of foreign DNA, is not clear.  Despite 
some minor variability, one common theme exists: A. baumannii, distinctively different from 
other species of Acinetobacter, maintains a preference for genes originating from Acinetobacter 
phage Bϕ-B1251.  This particular phage is found in environmental strains as well, but not as 
significantly as A. baumannii.  This phage may not be conserved or selected for in these species 
because it does not confer benefit.  Alternatively, these species may first be selecting for the 
benefits this phage may bestow.  Because non-baumannii Acinetobacter species are first being 
recognized as causative agents of human infection, it is possible that this trend is due to the 
recent acquisition of incomplete Bϕ-B1251 elements.  However, many more strains must be 
sequenced in order to analyze this theory. 
As evidenced by Tables 5-7, A. baumannii continues to acquire antibiotic resistance 
determinants and virulence factors.  The changes in resistance profiles vary among strains, but 
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one pattern is consistent: this species is becoming more resistant every year.  During this time, it 
continues to be exposed to other phages, but seems to maintain preference for the Bϕ-B1251 
phage genome.  Our data demonstrates that the maintenance of Bϕ-B1251 phage elements 
corresponds with A. baumannii’s growing antibiotic resistance patterns.  The unique inclination 
towards maintaining Bϕ-B1251 phage elements differentiates A. baumannii from other species of 
Acinetobacter that only rarely cause human infections and do not possess the same degree of 




VII. FUTURE DIRECTIONS AND IMPLICATIONS 
 Antibiotic resistant bacteria are inescapable in healthcare, and much attention has been 
given towards the discovery of novel therapeutics to kill pathogenic bacteria.  One popular 
alternative suggests using bacteriophages as predacious agents (Abedon, 2014).  Bacteriophages 
only are capable of killing their bacterial host and pose no harm to humans, as opposed to many 
toxic antibiotics.  Phage therapy has been shown to be promising for a number of infections, 
especially against biofilm-producing organisms that are difficult to treat using antibiotics 
(Semler, Lynch, & Dennis, 2011; Waters et al., 2017).  In 2012, Drs. Jongsoo Jeon and Jae-won 
Kim published an article suggesting the use of Acinetobacter phage YMC/09/02/B1251 ABA AP 
(synonymous to phage Bϕ-B1251) as therapy for A. baumannii infections.  They noted that this 
phage was successful in killing a strain of carbapenem-resistant A. baumannii and concluded that 
this phage would be useful in treating patients with sepsis due to multi-drug resistant A. 
baumannii (Jeon, Kim, Yong, Lee, & Chong, 2012). 
 However, because this phage was found to lie defective within the genomes of a majority 
of sequenced A. baumannii isolates, this bacteriophage does not always behave as we might 
expect.  The mutations we observed in A. baumannii represent the consequences that may result 
when a phage is incapable of producing lysis.  Rather than killing bacteria, prophages (once 
defective) may actually cause bacteria to become more virulent.  Careful consideration must 
especially be given to the Bϕ-B1251 phage if used as therapy.  This single phage, as opposed to 
numerous others known to infect A. baumannii, is often maintained by this organism. 
 The interactions between bacterial pathogens and bacteriophages are not as simple or 
straightforward as some may believe them to be.  More respect must be shown towards 
bacteriophages and their important role in bacterial evolution.  Deliberately introducing 
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pathogenic bacteria to bacteriophages within the human biome may not only be ineffective, but 
catastrophic. 
 Hope, however, should not be lost.  Numerous alternatives to antibiotics are now being 
tested.  These include initiatives such as utilization of the CRISPR/Cas9 system to resensitize 
bacteria to antibiotics, competition by predatory bacteria, exposure of pathogens to UV light, or 
even vaccination against anticipated bacterial threats.  As explained above, just as caution must 
be exercised before accepting bacteriophages as a means of therapy, all of these new alternatives 
must be well understood before being implemented in healthcare.  Just as the development of 
antibiotics had consequences we are facing today, other unforeseen consequences may result 
from the use of these new therapies.  With careful study, scientific discourse, and the expanding 
pool of resources available today, a community of scientists will be able to elucidate the best 
future therapy.  Studies such as ours are essential to provide more information about possible 
consequences as we proceed through this journey.   
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Table 1. Numbers and Types of Infections due to Acinetobacter baumannii by Year at a Single 
Hospital in Louisville, KY 
 
 2010 2011 2012 2013 2014 2015 2016 % in 
2016 
Blood Cultures 13 10 17 15 12 15 16 9.6 
Anaerobic  8 15 19 10 15 18 19 11.4 
Body Fluids 12 3 3 1 0 1 0  
Bone 0 2 0 0 0 0 0  
Catheter tip 2 3 1 2 4 0 2 1.2 
Cerebral Spinal 
Fluid 
1 0 0 0 0 1 0  
Duodenal 0 0 0 0 0 1 0  
Eye/Ear 0 0 3 2 1 1 1 0.6 
Genital 0 0 0 0 0 1 0  
Respiratory 37 95 66 52 34 29 43 25.9 
Tissue 7 3 11 8 5 9 8 4.8 
Urine 19 21 21 18 14 18 30 18 
Wound 20 26 29 35 20 36 47 28.3 
         
Total Number per 
year 
119 178 170 143 105 130 166  
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Table 2. Clinical isolates of Acinetobacter baumannii used for analysis 
 
Date Isolated Strain* Source Location  
1950 CIP70.10 Skin United States 
1951 ATCC 17978 Cerebrospinal Fluid France  
1982 A1 Unknown United Kingdom 
1994 AB307-0294 Blood Buffalo, New York 
1/2/1997 LAC-4 Hospital Outbreak Los Angeles, California 
2001 AYE Urine France 
2004 AB0057 Blood Washington DC 
2005 ACICU Cerebrospinal Fluid Rome, Italy  
4/20/2006 MDR-ZJ06 Blood Zhejiang, China 
3/1/2007 BJAB0868 Ascites Beijing, China 
2007 TCDC-AB0715 Unknown Taiwan 
10/19/2008 D36 Hospital Outbreak Sydney, Australia 
2009 XH860 Unknown Hangzhou, China 
2010 XH857 Sputum Guangdong, China 
3/1/2010 XH858 Sputum Zhejiang China 
7/31/2011 AC29 Endotracheal Aspirate Malaysia 
7/14/2012 Ab04-mff Blood Edmonton, Canada 
10/28/2012 BU310 Urine Louisville, Kentucky 
11/8/2012 BR097 Sputum Louisville, Kentucky 
2013 IOMTU433 Unknown Nepal 
5/29/2014 XH386 Sputum Hangzhou, China 
8/29/2014 AB030 Blood Winnipeg, Canada 
  






















CIP70.10 2 0 0 1 1 
ATCC 17978 3 1 1 1 2 
A1 4 2 1 2 2 
AB307-0294 2 1 0 1 1 
LAC-4 4 0 2 0 4 
AYE 0 0 0 0 0 
AB0057 6 1 3 1 5 
ACICU 3 2 1 2 1 
MDR-ZJ06 5 3 0 4 1 
BJAB0868 3 0 2 0 3 
D36 5 2 0 4 1 
XH860 4 0 3 1 3 
XH857 3 1 0 1 2 
XH858 5 0 3 1 4 
TCDC-AB0715 8 1 3 2 6 
AC29 3 1 2 1 2 
Ab04-mff 4 1 2 1 3 
BU310 10 0 6 1 9 
BR097 5 0 4 1 4 
IOMTU433 5 2 1 2 3 
XH386 5 1 1 3 2 
AB030 15 2 3 4 11 
 
1 No plasmid data is included in analysis 














Table 4. Prophages Other than Acinetobacter phage Bφ-B1251 Found 
 
STRAIN Other Intact Prophages Other Cryptic Prophages 
CIP70.10 Mannheimia phage vB MhM 
3927AP2 
Pseudomonas phage Pf3 
ATCC 17978 Enterobacteria phage mEp235  
A1 Psychrobacter phage pOW20-A  
AB307-0294  Psychrobacter phage pOW20-A 
LAC-4  Stx2-converting phage 1717 
Pelagiphage HTVC010P 
AYE   
AB0057  Cronobacter phage ENT39118 
Acinetobacter phage AP22 
ACICU   
MDR-ZJ06 Haemophilus phage SuMu Enterobacteria phage SfV 
BJAB0868   
D36 Mannheimia phage vB MhM 
3927AP2 
Psychrobacter phage Psymv2 
Burkholderia phage phi6442 
XH860 Enterobacteria phage mEp235  
XH857  Escherichia phage PA2 
Enterobacteria phage P1 
XH858 Mannheimia phage vB MhM 
3927AP2 
Escherichia phage PA2 
TCDC-AB0715 Mannheimia phage vB MhM 
3927AP2 
Pseudomonas phage F116 
Psychrobacter phage pOW20-A 
Salmonella phage F11SE 
AC29   
Ab04-mff  Myxococcus phage Mx8 
BU310 Psychrobacter phage Psymv2 Megavirus chiliensis 
Invertebrate iridescent virus 6 
Faustovirus 
BR097 Psychrobacter phage Psymv2  
IOMTU433  Acinetobacter phage AP22 
Enterobacteria phage mEp235 
XH386 Enterobacteria phage mEp235 
Salmonella phage SEN34 
Enterobacteria phage mEp235 
AB030 Enterobacteria phage mEp235 










Table 5. Resistance Genes Identified in Acinetobacter baumannii Strains by CARD* 
 
*CARD data was limited to perfect matches; strict and loose matches were not included in this 
analysis  
1950 CIP70.10 adeK, mexT, OXA-64 
1951 ATCC 17978 adeK, adeR 
1982 A1 adeK, adeR, adeA, abeS, aadA,  catI, mexT, OXA-69 
1994 AB307-0294 adeK, adeI, adeA, abeS, mexT, OXA-69 
1997 LAC-4 adeK, adeI, abeS, mexT, sul2, OXA-68, OXA-235 
2001 AYE adeK, adeI, adeR, adeA, abeS, aadA, arr-2, catI, dfrA10, mexT, 
OXA-10, OXA-69, APH (3')-la, VEB-1 
2004 AB0057 adeK, adeR, adeA, abeS, aadA,  catI, mexT, OXA-69, OXA-23, APH 
(3')-la, TEM-1 
2005 ACICU adeK, abeS, mexT, OXA-66, sul1 
2006 MDR-ZJ06 aadA, calB6, OXA-23, OXA-66, sul1 
2007 TCDC-AB0715 aadA, abeS, catB8, mexT, OXA-23, OXA-66, sul1, sul2, TEM-1, 
APH(3')-la 
2007 BJAB0868 abeS, ADC-2, mexT, OXA-23, TEM-1 
2008 D36 adeK, adeI, adeR, adeA, abeS, mexT, OXA-23, OXA-69 
2009 XH860 adeK, adeI, abeS, mexT, OXA-23, OXA-66, APH(3')-1a 
2010 XH857 abeS, aadA, armA, catB8, mexT, msrE, OXA-23. OXA-66, sul1, 
TEM-1, APH (3')-la 
2010 XH858 adeK, abeS, mexT, OXA-23, OXA-68 
2011 AC29 adeK, abeS, armA, mexT, msrE, OXA-66, APH (3')-la, TEM-1 
2012 Ab04-mff adeK, adeI, abeS, mexT, OXA-23, OXA-68, sul2 
2012 BU310 abeS, mexT, OXA-95 
2012 BR097 adeK, adeI abeS, aadA, armA, catB8, mexT, msrE, OXA-23, OXA-
24, OXA-66, OXA-95, sul1, APH (3')-Ia, TEM-1 
2013 IOMTU433 adeK, adeI, mexT, NDM-1, OXA-23, OXA-104, bleomycin 
resistance protein (BRP) 
2014 XH386 adeI, abeS, aadA, armA, CATB8, mexT, msrE, OXA-23, OXA-66, 
sul1, TEM-1, APH(3')-la 
2014 AB030 adeK, abeS, mexT, OXA-23, OXA-65, sul2, TEM-1 
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CIP70.10 1  2 2 2  1 1 1   1 2  1   2 1  
ATCC 
17978 1  1 1 1  1 1 1   2 1     2 1  
A1 1 1 2 3 2  1 1 1   2 2  3   5 2  
AB307-
0294 2  3 3 3  2 2 2   3 3  1   5 1  
LAC-4 2  4 3 3  2 2 2  1 2 3  2  1 4 1  
AYE 2 2 5 4 3  2 2 3   4 4  7  1 6 2  
AB0057 1 2 3 3 2  1 1 1   3 2  6   5 2  
ACICU 1  2 2 2  1 1 1  1 1 2  1  1 3 1  
MDR-
ZJ06  1 2 1       1    4  1    
TCDC-
AB0715  2 3 2 1      2  1  6  2 2 1  
BJAB086
8   3 1 1        1  3   2 1  
D36 2  4 3 3  2 2 2   4 3  2   6 2  
XH860 2 1 5 3 3  2 2 2   2 3  4   4 1  
XH857  3 3 1       1    6 1 1 3 1  
XH858 1  3 2 2  1 1 1   1 2  2   3 1  
AC29 1 2 3 2 2  1 2 1 1  1 2  3 1  4 1  
Ab04-mff 2  4 3 3  2 2 2   2 3  2   4 1  
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BU310                     
BR097  3 5 2       1    8 1 1 4 1  
IOMTU-
433   3   1         3   3 1 1 
XH386 1 1 4 3 2  1 2 1 1 1 1 2  6 1 1 4 1  






Table 7. Descriptions of Resistance Genes Identified by CARD 
 
Gene Name Effects on Resistance  Description 
aadA antibiotic inactivation enzyme, 
aminoglycoside resistance 
ANT(3'')-Ia is an aminoglycoside 
nucleotidyltransferase gene encoded by 
plasmids, transposons, integrons in 
Enterobacteriaceae, A. baumannii, P. 
aeruginosa and Vibrio cholerae 
abeS efflux pump conferring resistance AbeS in an efflux pump of the SMR family 
of transporters found in Acinetobacter 
baumannii. 
ADC-2 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
ADC-25 is a beta-lactamase found in 
Acinetobacter baumannii. 
adeA efflux pump conferring resistance, 
tetracycline resistance gene 
AdeA is the membrane fusion protein of the 
multidrug efflux complex AdeABC. 
adeI efflux pump conferring resistance, 
tetracycline resistance gene, fluorquinolone 
resistance gene, chloramphenicol resistace 
gene, trimethoprim resistance gene, beta-
lactam resistance gene, macrolide resistance 
gen, aminocoumarin resistance gene, 
lincosamide resistance gene, rifampin 
resistance gene 
AdeI is the membrane fusion protein of the 
AdeIJK multidrug efflux complex. 
adeK efflux pump conferring resistance, 
tetracycline resistance gene, fluorquinolone 
resistance gene, chloramphenicol resistace 
gene, trimethoprim resistance gene, beta-
lactam resistance gene, macrolide resistance 
gen, aminocoumarin resistance gene, 
lincosamide resistance gene, rifampin 
resistance gene 
AdeK is the outer membrane factor protein in 
the adeIJK multidrug efflux complex. 
adeR gene modulating antibiotic efflux, efflux 
pump conferring resistance, tetracycline 
resistance gene 
AdeR is a positive regulator of AdeABC 
efflux system. AdeR inactivation leads to 
susceptibility to aminoglycoside antibiotics 
APH(3')-1a antibiotic inactivation enzyme, 
aminoglycoside resistance 
APH(3')-Ia is a transposon-encoded 
aminoglycoside phosphotransferase in E. coli 
and S. enterica. It is identical at the protein 
sequence to APH(3')-Ic, an aminoglycoside 
phosphotransferase encoded by plasmids, 
transposons and genomic islands in K. 
pneumoniae, A. baumannii, S. marcescens, 
Corynebacterium spp., Photobacterium spp. 
and Citrobacter spp. 
armA aminoglycoside resistance gene, antibiotic 
target modifying enzyme 
ArmA is a 16S rRNA methyltransferase that 
targets mature or nearly mature 30S subunits. 
It transfers a methyl group from S-adenosyl-
L-methionine to N7-G1405 of the 16S 
rRNA, an aminoglycoside binding site. 
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arr-2 antibiotic inactivation enzyme, rifampin 
resistance gene 
arr-2 is an integron-encoded 






gene involved in antibiotic sequestration, 
glycopeptide resistance gene 
A diverse set of acidic proteins that are able 
to complex bleomycin and thus prevent 
bleomycin-induced DNA cleavage 
catB6 antibiotic inactivation enzyme, 
chloramphenicol resistance 
catB6 is a plasmid-encoded variant of the cat 
gene found in Pseudomonas aeruginosa 
catB8 antibiotic inactivation enzyme, 
chloramphenicol resistance 
catB8 is a plasmid or integron-encoded 
variant of the cat gene found in Klebsiella 
pneumoniae, Salmonella typhi and 
Pseudomonas aeruginosa 
catI antibiotic inactivation enzyme, 
chloramphenicol resistance 
catI is a chromosome and transposon-
encoded variant of the cat gene found in 
Escherichia coli and Acinetobacter 
baumannii 
dfrA10 trimethoprim resistance, antibiotic target 
replacement protein 
dfrA10 is an integron-encoded dihydrofolate 
reductase found in Klebsiella pneumoniae 
mexT efflux pump conferring antibiotic resistance, 
gene modulating antibiotic efflux 
MexT is a LysR-type transcriptional 
activator that positively regulates the 
expression of MexEF-OprN and OprD. 
msrE efflux pump conferring resistance, 
macrolide resistance gene, streptogramin 
resistance gene 
MsrE is an ABC-efflux pump expressed to 
Klebsiella pneumoniae that confers 
resistance to erythromycin and streptogramin 
B antibiotics. It is associated with plasmid 
DNA. 
NDM-1 beta-lactam resistance gene, antibiotic 
inactivation enzyme, meropenem, 
imipenem, carbapenem, cephalosporin 
resistance 
NDM-1 is a metallo-beta-lactamase isolated 
from Klebsielle pneumoniae with nearly 
complete resistance to all beta-lactam 
antibiotics 
OXA-10 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-10 is a beta-lactamase found in 
Acinetobacter baumannii and P. aeruginosa 
OXA-23 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-23 is a beta-lactamase found in A. 
baumannii 
OXA-24 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-24 is a beta-lactamase found in A. 
baumannii and P. aeruginosa 
OXA-64 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-64 is a beta-lactamase found in A. 
baumannii 
OXA-66 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-66 is a beta-lactamase found in A. 
baumannii 
OXA-68 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-68 is a beta-lactamase found in A. 
baumannii 
OXA-69 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-69 is a beta-lactamase found in A. 
baumannii 
OXA-95 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-95 is a beta-lactamase found in A. 
baumannii 
OXA-104 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-104 is a beta-lactamase found in A. 
baumannii 
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OXA-235 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
OXA-235 is a beta-lactamase found in A. 
baumannii 
sul1 antibiotic target replacement 
protein,sulfonamide resistance gene 
Sul1 is a sulfonamide resistant 
dihydropteroate synthase of Gram-negative 
bacteria. It is linked to other resistance genes 
of class 1 integrons. 
sul2 antibiotic target replacement 
protein,sulfonamide resistance gene 
Sul2 is a sulfonamide resistant 
dihydropteroate synthase of Gram-negative 
bacteria, usually found on small plasmids. 
TEM-1 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
TEM-1 is a broad-spectrum beta-lactamase 
found in many Gram-negative bacteria 
VEB-1 beta-lactam resistance gene, antibiotic 
inactivation enzyme 
VEB-1 is a beta-lactamase found in 




Table 8. Genomic Comparisons of Phages and Antibiotic Resistance Genes 
 
Year Collected A. baumannii Strain 
Number of Antibiotic 
Resistance Genes 
Identified 





1950 CIP70.10 3 1 1 
1951 ATCC 17978 2 1 2 
1982 A1 8 2 2 
1994 AB307-0294 6 1 1 
1997 LAC-4 7 0 4 
2001 AYE 13 0 0 
2004 AB0057 11 1 5 
2005 ACICU 5 2 1 
2006 MDR-ZJ06 5 4 1 
2007 TCDC-AB0715 10 0 3 
2007 BJAB0868 5 4 1 
2008 D36 8 1 3 
2009 XH860 7 1 2 
2010 XH857 11 1 4 
2010 XH858 5 2 6 
2011 AC29 8 1 2 
2012 Ab04-mff 7 1 3 
2012 BU310 3 1 9 
2012 BR097 15 1 4 
2013 IOMTU433 7 2 3 
2014 XH386 12 3 2 














baylyi ADP1 CR543861.1 Soil 
baylyi DSM 14961 (CIP 107474) PRJNA183290 Activated sludge plant 
calcoaceticus PHEA-2 CP002177.1 Industry wastewater 
calcoaceticus RUH2202 PRJNA38337 Skin flora 
gerneri DSM 14967 PRJNA224116 Activated sludge plant 
haemolyticus ATCC 19194 SAMN01917633 Nose flora 
haemolyticus TJS01 CP018871.1 CLINICAL- respiratory 
johnsonii SH046 PRJNA38339 Skin flora 
johnsonii XBB1 CP010350.1 Hospital sewage 
junii 65 CP019041.1 Limnetic water 
junii SH205 PRJNA38341 GI flora 
lwoffii SH145 SAMN02463731 Skin flora 
nosocomialis 6411 CP010368.1 CLINICAL 
oleivorans DR1 NC_014259 Rice paddy soil 
parvus NIPH 1103 490813056 Skin flora 
pittii ATCC 19004 (CIP 70.29)   
pittii AP 882 CP014477.1  CLINICAL-wound 
radioresistens SH164 PRJNA38345 GI flora 
radioresistens SK82 PRJNA34081 Skin flora 
soli GFJ2 CP016896.1 Industrial, soil 













Intact Prophages Incomplete Prophages 
Questionable 
Prophages 
baylyi 1  Psychro pOW20  
baylyi 1  Psychro pOW20  
calcoaceticus 0    
calcoaceticus 1   Acinet Bphi B1251 
gerneri 1 Burkho phiE255   
haemolyticus 1 Acinet Bphi B1251   
haemolyticus 2 Pectob PP90 Enterofi AA91  
johnsonii 1 Entero mEp235   
johnsonii 4 Pseduo PhiCTX Paenib tripp Entero tyrion, Acinet Bphi B1251 
junii 2 Entero mEp235  Paenib tripp 
junii 3 Entero mEp235, Stx2 c 1717 Acinet Bphi B1251  
lwoffii 2 Shewan MR-1 Acinet Bphi B1251  
nosocomialis 1   Pseudo JBD93 
oleivorans 2 Entero cdtl   Acinet Bphi B1251 
parvus 1 Pseudo B3   
pittii 1  Burkho BcepMu  
pittii 1   Cronob vB GAP32 
radioresistens 2  Acinet Bphi B1251  
radioresistens 5 Entero mEp235, Acinet Bphi B1251 
Acinet Bphi B1251, 
Ostreo 2  
soli 4 Manhe vB MhM 3927AP2 Phage phiJL001 Acinet Bphi B1251 




Graph 1. Total Phage Elements.  A. baumannii strains isolated after 2000 appear to have 




Graph 2. Number of Incomplete Phages.  A steady rise in the number of incomplete prophage 
elements harbored by A. baumannii mirrors the rise in total phage elements (Graph 1).  This rise 




Graph 3. Number of Incomplete Bφ-B1251. Compared to Graphs 1 and 2, the increase in both 
total phage elements and incomplete phages also mirrors the increase in incomplete Bφ-B1251 
elements.  This single phage seems to be the most well-maintained phage element and is 











































































Graph 4. Total phage elements projected with exponential trendline.  Because different 
strains evolve at varying rates, only the most “evolved” strains were analyzed.  Of these, a clear 
exponential pattern of phage acquisition (both intact and incomplete) was discerned 
 
 
Graph 5. Number of incomplete phages projected with exponential trendline.  Again, a clear 
exponential pattern of incomplete phage acquisition was discerned, suggesting that the evolution 




Graph 6. Number of incomplete Bφ-B1251 phages projected with exponential trendline.  
Finally, a clear exponential pattern of incomplete Bφ-B1251 phage maintenance was also 
discerned.  Therefore, of the incomplete phages contributing to A. baumannii diversity, 












































































































Figure 1. Placement of phage genes nearby antibiotic resistance genes and transcriptional 
regulators.  Shown is contig 2 of A. baumannii BR097 bp 600679..622441 (begins at first line (a) 
and continues down to next line (b)). In this example, a phage replication initiation protein is 
located upstream from an RND multidrug efflux transporter and transcriptional regulator.  Image 















































Figure 2. Genomic comparisons of A. baumannii BR097 and BU310 against reference strain A. 
baumannii ATCC 17978.  The outermost ring represents BR097, while the inner ring represents 
the genome of BU310.  The colors of each line within the ring (representing a gene within the 
genome) correspond to the percent of homology, ranging from dark blue (100%) to red.  Areas of 
white represent novel genetic material that was not found within the reference genome and is, 
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